Therese Andersson

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

Jag är biostatistiker och forskar främst inom cancerepidemiologi. Jag är
speciellt intresserad av cancerpatientöverlevnad, och utvecklar och
tillämpar avancerade statistiska metoder inom detta fält. Mer information
hittas på den engelska versionen av denna sida.

Artiklar

Journal article: EUROPEAN JOURNAL OF CANCER. 2024;202:113980

Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016: The NORDCAN survival studies

Lundberg FE; Birgisson H; Engholm G; Ólafsdóttir EJ; Mørch LS; Johannesen TB; Pettersson D; Lambe M; Seppä K; Lambert PC; Johansson ALV; Hölmich LR; Andersson TM-L
Article: JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH. 2024;:jech-2024-221916

Income disparities in loss in life expectancy after colon and rectal cancers: a Swedish register-based study.

Syriopoulou E; Osterman E; Miething A; Nordenvall C; Andersson TM-L
Article: LEUKEMIA. 2024;:1-5

Childbirth rates in women with myeloproliferative neoplasms.

Landtblom AR; Andersson TM-L; Johansson ALV; Lundberg FE; Samuelsson J; Björkholm M; Hultcrantz M
Journal article: EUROPEAN UROLOGY. 2024;85:s52

P038 Stage-specific survival among men with prostate cancer in the Nordic countries 2004-2016 - the NORDCAN survival studies

Larsen SB; Lundberg FE; Friis S; Birgisson H; Andersson TML; Engholm G; Lambert PC; Lambe M; Pettersson D; Ólafsdóttir E; Johannesen TB; Kønig SM; Johansson ALV; Mørch LS
Article: EUROPEAN JOURNAL OF CANCER. 2024;202:113980

Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016: The NORDCAN survival studies.

Lundberg FE; Birgisson H; Engholm G; Ólafsdóttir EJ; Mørch LS; Johannesen TB; Pettersson D; Lambe M; Seppä K; Lambert PC; Johansson ALV; Hölmich LR; Andersson TM-L
Article: EUROPEAN JOURNAL OF CANCER. 2024;199:113572

Despite multi-disciplinary team discussions the socioeconomic disparities persist in the oncological treatment of non-metastasized colorectal cancer.

Osterman E; Syriopoulou E; Martling A; Andersson TM-L; Nordenvall C
Article: COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION. 2024;53(2):993-1006

Potential bias introduced by not including multiple time-scales in survival analysis: a simulation study

Batyrbekova N; Bower H; Dickman PW; Szulkin R; Lambert PC; Andersson TM-L
Article: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2024;:S0190-9622(24)00056-2

Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort study.

Vikström S; Syriopoulou E; Andersson TM-L; Eriksson H
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2023;23(1):291

Including uncertainty of the expected mortality rates in the prediction of loss in life expectancy.

Leontyeva Y; Lambe M; Bower H; Lambert PC; Andersson TM-L
Article: BRITISH JOURNAL OF CANCER. 2023;129(5):819-828

Improving communication of cancer survival statistics-feasibility of implementing model-based algorithms in routine publications.

Myklebust TÅ; Aagnes B; Nilssen Y; Rutherford M; Lambert PC; Andersson TML; Johansson ALV; Dickman PW; Møller B
Article: JNCI CANCER SPECTRUM. 2023;7(3):pkad038

Reranking cancer mortality using years of life lost.

Radkiewicz C; Andersson TM-L; Lagergren J
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2023;23(1):87

Exploring different research questions via complex multi-state models when using registry-based repeated prescriptions of antidepressants in women with breast cancer and a matched population comparison group.

Skourlis N; Crowther MJ; Andersson TM-L; Lu D; Lambe M; Lambert PC
Article: ACTA ONCOLOGICA. 2023;62(2):103-109

Seasonal effects on cancer incidence and prognosis.

Wikén I; Andersson TM-L; Radkiewicz C
Article: BRITISH JOURNAL OF DERMATOLOGY. 2023;188(1):32-40

Association of metformin use and survival in patients with cutaneous melanoma and diabetes.

Krakowski I; Häbel H; Nielsen K; Ingvar C; Andersson TML; Girnita A; Smedby KE; Eriksson H
Article: ACTA ONCOLOGICA. 2022;61(12):1481-1489

Age-specific survival trends and life-years lost in women with breast cancer 1990-2016: the NORDCAN survival studies.

Lundberg FE; Kroman N; Lambe M; Andersson TM-L; Engholm G; Johannesen TB; Virtanen A; Pettersson D; Ólafsdóttir EJ; Birgisson H; Lambert PC; Mørch LS; Johansson ALV
Article: BRITISH JOURNAL OF CANCER. 2022;127(10):1808-1815

Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data.

Syriopoulou E; Wästerlid T; Lambert PC; Andersson TM-L
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2022;22(1):290

Modelling multiple time-scales with flexible parametric survival models.

Batyrbekova N; Bower H; Dickman PW; Ravn Landtblom A; Hultcrantz M; Szulkin R; Lambert PC; Andersson TM-L
Article: ACTA ONCOLOGICA. 2022;61(11):1377-1385

Cardiovascular, bone, and metabolic health in men with castrate-resistant prostate cancer treated with androgen deprivation: a matched cohort study.

Khoshkar Y; Vigneswaran HT; Eloranta S; Andersson TM-L; Schain F; Boman A; Dahlkild M; Liwing J; Leval A; Akre O; Aly M
Article: BRITISH JOURNAL OF CANCER. 2022;127(6):1061-1068

Obtaining long-term stage-specific relative survival estimates in the presence of incomplete historical stage information.

Stannard R; Lambert PC; Andersson TM-L; Rutherford MJ
Article: BIOMETRICAL JOURNAL. 2022;64(7):1161-1177

On the choice of timescale for other cause mortality in a competing risk setting using flexible parametric survival models.

Skourlis N; Crowther MJ; Andersson TM-L; Lambert PC
Article: LEUKEMIA. 2022;36(10):2461-2467

Pregnancy and childbirth outcomes in women with myeloproliferative neoplasms-a nationwide population-based study of 342 pregnancies in Sweden.

Landtblom AR; Andersson TM-L; Johansson ALV; Wendel SB; Lundberg FE; Samuelsson J; Björkholm M; Hultcrantz M
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2022;31(9):1720-1726

Reference-Adjusted Loss in Life Expectancy for Population-Based Cancer Patient Survival Comparisons-with an Application to Colon Cancer in Sweden.

Andersson TM-L; Rutherford MJ; Møller B; Lambert PC; Myklebust TÅ
Article: EUROPEAN JOURNAL OF CANCER. 2022;172:76-84

Survival trends in patients diagnosed with colon and rectal cancer in the nordic countries 1990-2016: The NORDCAN survival studies.

Lundberg FE; Birgisson H; Johannesen TB; Engholm G; Virtanen A; Pettersson D; Ólafsdóttir EJ; Lambe M; Lambert PC; Mørch LS; Johansson ALV; Andersson TM-L
Article: STATA JOURNAL. 2022;22(3):679-701

Flexible parametric survival analysis with multiple timescales: Estimation and implementation using stmt

Bower H; Andersson TM-L; Crowther MJ; Lambert PC
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2022;31(6):1168-1175

Quantifying Differences in Remaining Life Expectancy after Cancer Diagnosis, Aboriginal and Torres Strait Islanders, and Other Australians, 2005-2016.

Dasgupta P; Andersson TM-L; Garvey G; Baade PD
Article: CANCERS. 2022;14(10):2349

Health Anxiety and Its Relationship to Thyroid-Hormone-Suppression Therapy in Patients with Differentiated Thyroid Cancer.

Zoltek M; Andersson TM-L; Axelsson E; Hedman C; Ihre Lundgren C
Article: BRITISH JOURNAL OF CANCER. 2022;126(8):1224-1228

Five ways to improve international comparisons of cancer survival: lessons learned from ICBP SURVMARK-2.

Andersson TM-L; Myklebust TÅ; Rutherford MJ; Møller B; Arnold M; Soerjomataram I; Bray F; Parkin DM; Lambert PC
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2022;22(1):130

Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy.

Leontyeva Y; Bower H; Gauffin O; Lambert PC; Andersson TM-L
Article: BREAST CANCER RESEARCH. 2022;24(1):15

Assessing lead time bias due to mammography screening on estimates of loss in life expectancy.

Syriopoulou E; Gasparini A; Humphreys K; Andersson TM-L
Article: CANCER EPIDEMIOLOGY. 2022;76:102085

A way to explore the existence of "immortals" in cancer registry data - An illustration using data from ICBP SURVMARK-2.

Andersson TM-L; Rutherford MJ; Myklebust TÅ; Møller B; Arnold M; Soerjomataram I; Bray F; Elkader HA; Engholm G; Huws D; Little A; Shack L; Walsh PM; Woods RR; Parkin DM; Lambert PC
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2022;22(1):2

Non-parametric estimation of reference adjusted, standardised probabilities of all-cause death and death due to cancer for population group comparisons.

Rutherford MJ; Andersson TM-L; Myklebust TÅ; Møller B; Lambert PC
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2021;21(1):262

Development of a dynamic interactive web tool to enhance understanding of multi-state model analyses: MSMplus.

Skourlis N; Crowther MJ; Andersson TM-L; Lambert PC
Article: BREAST CANCER RESEARCH. 2021;23(1):109

Self-reported arm and shoulder problems in breast cancer survivors in Sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort study.

Boucheron P; Anele A; Zietsman A; Galukande M; Parham G; Pinder LF; Andersson TM-L; Anderson BO; Foerster M; Schüz J; Dos Santos Silva I; McCormack V
Article: COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION. 2021;50(11):3777-3793

Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study

Bower H; Crowther MJ; Rutherford MJ; Andersson TM-L; Clements M; Liu X-R; Dickman PW; Lambert PC
Article: JOURNAL OF CLINICAL EPIDEMIOLOGY. 2021;137:92-103

Temporal improvements noted in life expectancy of patients with colorectal cancer; a Dutch population-based study.

Qaderi SM; Andersson TML; Dickman PW; de Wilt JHW; Verhoeven RHA
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2021;55(4):299-306

Real world treatment utilization patterns in patients with castration-resistant prostate cancer.

Vigneswaran HT; Warnqvist A; Andersson TML; Leval A; Eklund M; Nordström T; Eloranta S; Schain F; Dearden L; Liwing J; Mehra M; Nair S; Pettersson A; Akre O; Aly M
Article: ARCHIVES OF SUICIDE RESEARCH. 2021;25(3):424-438

Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study.

Reutfors J; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Brenner P
Article: CANCERS. 2021;13(10):2456

The Proportion Cured of Patients with Resected Stage II-III Cutaneous Melanoma in Sweden.

Eriksson H; Utjés D; Olofsson Bagge R; Gillgren P; Isaksson K; Lapins J; Schultz IL; Lyth J; Andersson TM-L
Article: STATISTICS IN MEDICINE. 2021;40(9):2139-2154

A multistate model incorporating estimation of excess hazards and multiple time scales.

Weibull CE; Lambert PC; Eloranta S; Andersson TML; Dickman PW; Crowther MJ
Article: CANCER EPIDEMIOLOGY. 2021;71(Pt A):101881

The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study.

Andersson TM-L; Myklebust TÅ; Rutherford MJ; Møller B; Soerjomataram I; Arnold M; Bray F; Parkin DM; Sasieni P; Bucher O; De P; Engholm G; Gavin A; Little A; Porter G; Ramanakumar AV; Saint-Jacques N; Walsh PM; Woods RR; Lambert PC
Article: BRITISH JOURNAL OF CANCER. 2021;124(5):1026-1032

Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study.

Andersson TM-L; Rutherford MJ; Myklebust TÅ; Møller B; Soerjomataram I; Arnold M; Bray F; Parkin DM; Sasieni P; Bucher O; De P; Engholm G; Gavin A; Little A; Porter G; Ramanakumar AV; Saint-Jacques N; Walsh PM; Woods RR; Lambert PC
Article: LEUKEMIA. 2021;35(2):476-484

Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients.

Landtblom AR; Andersson TM-L; Dickman PW; Smedby KE; Eloranta S; Batyrbekova N; Samuelsson J; Björkholm M; Hultcrantz M
Article: THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY. 2021;11:20451253211006508-204512532110065

Excess deaths in treatment-resistant depression.

Brenner P; Reutfors J; Nijs M; Andersson TM-L
Article: BIOMETRICS. 2020;76(4):1053-1063

A unified evaluation of differential vaccine efficacy.

Gabriel EE; Sachs MC; Follmann DA; Andersson TM-L
Article: ACTA ONCOLOGICA. 2020;59(11):1322-1328

Estimates of lung and pancreatic cancer survival in Sweden with and without inclusion of death certificate initiated (DCI) cases.

Lambe M; Wigertz A; Sandin F; Holmberg E; Amsler-Nordin S; Andersson TM-L; Pettersson D
Article: ACTA ONCOLOGICA. 2020;59(11):1266-1274

Trends in cancer survival in the Nordic countries 1990-2016: the NORDCAN survival studies.

Lundberg FE; Andersson TM-L; Lambe M; Engholm G; Mørch LS; Johannesen TB; Virtanen A; Pettersson D; Ólafsdóttir EJ; Birgisson H; Johansson ALV; Lambert PC
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2020;49(5):1614-1623

Reference-adjusted and standardized all-cause and crude probabilities as an alternative to net survival in population-based cancer studies.

Lambert PC; Andersson TM-L; Rutherford MJ; Myklebust TÅ; Møller B
Article: CANCER RESEARCH. 2020;80(16):3436-3442

Psychiatric Disorders Are Associated with Increased Risk of Sepsis Following a Cancer Diagnosis.

Liu Q; Song H; Andersson TM-L; Magnusson PKE; Zhu J; Smedby KE; Fang F
Article: CANCER EPIDEMIOLOGY. 2020;67:101759

Can different definitions of date of cancer incidence explain observed international variation in cancer survival? An ICBP SURVMARK-2 study.

Myklebust TÅ; Andersson T; Bardot A; Vernon S; Gavin A; Fitzpatrick D; Jerm MB; Rutherford M; Parkin DM; Sasieni P; Arnold M; Soerjomataram I; Bray F; Lambert PC; Møller B
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(7):740-748

Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma.

Wästerlid T; Harrysson S; Andersson TM-L; Ekberg S; Enblad G; Andersson P-O; Jerkeman M; Eloranta S; Smedby KE
Journal article: INVESTIGATIVE UROLOGY. 2020;203(Supplement 4)

PD10-06 REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

Vigneswaran* HT; Warnqvist A; Andersson TML; Leval A; Schain F; Liwing J; Eloranta S; Pettersson A; Akre O; Aly M
Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(4):448-454

Incidence of myeloproliferative neoplasms - trends by subgroup and age in a population-based study in Sweden.

Hultcrantz M; Ravn Landtblom A; Andréasson B; Samuelsson J; Dickman PW; Kristinsson SY; Björkholm M; Andersson TM-L
Article: CANCER EPIDEMIOLOGY. 2020;65:101686

Temporal trends in loss of life expectancy after a cancer diagnosis among the Australian population.

Kou K; Dasgupta P; Cramb SM; Yu XQ; Andersson TM-L; Baade PD
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2020;20(1):71

On estimating the time to statistical cure.

Jakobsen LH; Andersson TM-L; Biccler JL; Poulsen LØ; Severinsen MT; El-Galaly TC; Bøgsted M
Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2020;54(2):115-121

Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden.

Aly M; Leval A; Schain F; Liwing J; Lawson J; Vágó E; Nordström T; Andersson TM-L; Sjöland E; Wang C; Eloranta S; Akre O
Article: WORLD JOURNAL OF SURGERY. 2020;44(2):436-441

Cardiovascular Incidence in 6900 Patients with Differentiated Thyroid Cancer: a Swedish Nationwide Study.

Zoltek M; Andersson TM-L; Hedman C; Ihre-Lundgren C; Nordenvall C
Article: CLINICAL EPIDEMIOLOGY. 2020;12:737-744

The Occurrence of Metabolic Risk Factors Stratified by Psoriasis Severity: A Swedish Population-Based Matched Cohort Study.

Hajiebrahimi M; Song C; Hägg D; Andersson TM-L; Villacorta R; Linder M
Article: STATISTICAL METHODS IN MEDICAL RESEARCH. 2019;28(12):3822-3842

Joint models of tumour size and lymph node spread for incident breast cancer cases in the presence of screening.

Isheden G; Abrahamsson L; Andersson T; Czene K; Humphreys K
Article: LANCET ONCOLOGY. 2019;20(11):1493-1505

Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.

Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM-L; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
Article: INTERNATIONAL JOURNAL OF CANCER. 2019;145(5):1200-1208

Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients.

Weibull CE; Björkholm M; Glimelius I; Lambert PC; Andersson TML; Smedby KE; Dickman PW; Eloranta S
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2019;19(1):145

Illustration of different modelling assumptions for estimation of loss in expectation of life due to cancer.

Andersson TM-L; Rutherford MJ; Lambert PC
Article: BREAST. 2019;45:75-81

Potential gain in life years for Swedish women with breast cancer if stage and survival differences between education groups could be eliminated - Three what-if scenarios.

Bower H; Andersson TM-L; Syriopoulou E; Rutherford MJ; Lambe M; Ahlgren J; Dickman PW; Lambert PC
Article: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(9):703-713

Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study.

Biccler JL; Glimelius I; Eloranta S; Smeland KB; Brown PDN; Jakobsen LH; Frederiksen H; Jerkeman M; Fosså A; Andersson TML; Holte H; Bøgsted M; El-Galaly TC; Smedby KE
Article: EUROPEAN JOURNAL OF CANCER. 2019;110:42-48

Avoidable cancers in the Nordic countries-the potential impact of increased physical activity on postmenopausal breast, colon and endometrial cancer.

Andersson TM-L; Engholm G; Lund A-SQ; Lourenço S; Matthiessen J; Pukkala E; Stenbeck M; Tryggvadottir L; Weiderpass E; Storm H
Article: PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE. 2019;35(2):78-86

Skin cancer projections and cost savings 2014-2045 of improvements to the Danish sunbed legislation of 2014.

Køster B; Meyer MKH; Andersson TM-L; Engholm G; Dalum P
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2019;19(1):23

Estimating the loss of lifetime function using flexible parametric relative survival models.

Jakobsen LH; Andersson TM-L; Biccler JL; El-Galaly TC; Bøgsted M
Article: CLINICAL EPIDEMIOLOGY. 2019;11:1025-1034

Cardiovascular Diseases And Psychiatric Disorders During The Diagnostic Workup Of Suspected Hematological Malignancy.

Liu Q; Andersson TM; Jöud A; Shen Q; Schelin ME; Magnusson PK; Smedby KE; Fang F
Article: EUROPEAN JOURNAL OF CANCER. 2018;103:299-307

Avoidable cancers in the Nordic countries-The impact of alcohol consumption.

Andersson TM-L; Engholm G; Pukkala E; Stenbeck M; Tryggvadottir L; Storm H; Weiderpass E
Article: EUROPEAN JOURNAL OF CANCER. 2018;103:288-298

Tackling the tobacco epidemic in the Nordic countries and lower cancer incidence by 1/5 in a 30-year period-The effect of envisaged scenarios changing smoking prevalence.

Andersson TM-L; Engholm G; Brink A-L; Pukkala E; Stenbeck M; Tryggvadottir L; Weiderpass E; Storm H
Article: LEUKEMIA. 2018;32(10):2203-2210

Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients.

Landtblom AR; Bower H; Andersson TM-L; Dickman PW; Samuelsson J; Björkholm M; Kristinsson SY; Hultcrantz M
Article: MEDICINE. 2018;97(41):e12738

Development in sunburn 2007-2015 and skin cancer projections 2007-2040 of campaign results in the Danish population.

Køster B; Meyer M; Andersson T; Engholm G; Dalum P
Article: JOURNAL OF AFFECTIVE DISORDERS. 2018;238:674-679

Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden.

Reutfors J; Andersson TM-L; Brenner P; Brandt L; DiBernardo A; Li G; Hägg D; Wingård L; Bodén R
Article: BMJ OPEN. 2018;8(8):e022094

Sunbed use 2007-2015 and skin cancer projections of campaign results 2007-2040 in the Danish population: repeated cross-sectional surveys.

Køster B; Meyer MK; Andersson TM-L; Engholm G; Dalum P
Article: CANCER EPIDEMIOLOGY. 2018;55:1-7

Avoidable colorectal cancer cases in Denmark - The impact of red and processed meat.

Lourenço S; Gunge VB; Andersson TM-L; Andersen CLE; Lund A-SQ; Køster B; Hansen GL
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2018;:1020-1028

Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma.

Ekberg S; Jerkeman M; Andersson P-O; Enblad G; Wahlin BE; Hasselblom S; Andersson TM; Eloranta S; Smedby KE
Article: INTERNATIONAL JOURNAL OF CANCER. 2018;142(7):1343-1354

Tumor characteristics and prognosis in women with pregnancy-associated breast cancer.

Johansson ALV; Andersson TM-L; Hsieh C-C; Jirström K; Cnattingius S; Fredriksson I; Dickman PW; Lambe M
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2018;187(4):828-836

Adjusting Expected Mortality Rates Using Information From a Control Population: An Example Using Socioeconomic Status.

Bower H; Andersson TM-L; Crowther MJ; Dickman PW; Lambe M; Lambert PC
Article: ANNALS OF INTERNAL MEDICINE. 2018;168(5):317-325

Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms: A Population-Based Cohort Study.

Hultcrantz M; Björkholm M; Dickman PW; Landgren O; Derolf ÅR; Kristinsson SY; Andersson TML
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;186(9):1065-1073

Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach.

Andersson TM-L; Crowther MJ; Czene K; Hall P; Humphreys K
Article: BRITISH JOURNAL OF CANCER. 2017;117(9):1419-1426

Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England.

Syriopoulou E; Bower H; Andersson TM-L; Lambert PC; Rutherford MJ
Article: EUROPEAN JOURNAL OF CANCER. 2017;79:106-118

Avoidable cancer cases in the Nordic countries - The impact of overweight and obesity.

Andersson TM-L; Weiderpass E; Engholm G; Lund A-SQ; Olafsdottir E; Pukkala E; Stenbeck M; Storm H
Article: CANCER EPIDEMIOLOGY. 2017;46:50-56

Assessment of lead-time bias in estimates of relative survival for breast cancer.

Andersson TM-L; Rutherford MJ; Humphreys K
Article: BMC CANCER. 2017;17(1):2

Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.

Song H; Fang F; Valdimarsdóttir U; Lu D; Andersson TM-L; Hultman C; Ye W; Lundell L; Johansson J; Nilsson M; Lindblad M
Article: INTERNATIONAL JOURNAL OF CANCER. 2017;140(1):34-40

Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer.

Strand F; Humphreys K; Eriksson M; Li J; Andersson TML; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Article: JAMA ONCOLOGY. 2016;2(9):1188-1196

Clinical Diagnosis of Mental Disorders Immediately Before and After Cancer Diagnosis: A Nationwide Matched Cohort Study in Sweden.

Lu D; Andersson TML; Fall K; Hultman CM; Czene K; Valdimarsdóttir U; Fang F
Article: CANCER CAUSES & CONTROL. 2016;27(8):955-964

Temporal changes in loss of life expectancy due to cancer in Australia: a flexible parametric approach.

Baade PD; Youlden DR; Andersson TM; Youl PH; Walpole ET; Kimlin MG; Aitken JF; Biggar RJ
Article: INTERNATIONAL JOURNAL OF CANCER. 2016;138(12):2829-2836

The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study.

Eriksson H; Lyth J; Andersson TM-L
Article: BLOOD CANCER JOURNAL. 2016;6(2):e390

Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life.

Bower H; Andersson TM-L; Björkholm M; Dickman PW; Lambert PC; Derolf ÅR
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2015;90(12):1128-1134

Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics.

Glimelius I; Ekberg S; Jerkeman M; Chang ET; Björkholm M; Andersson TML; Smedby KE; Eloranta S
Article: JOURNAL OF CLINICAL ONCOLOGY. 2015;33(20):2288-2295

Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study.

Hultcrantz M; Wilkes SR; Kristinsson SY; Andersson TM-L; Derolf ÅR; Eloranta S; Samuelsson J; Landgren O; Dickman PW; Lambert PC; Björkholm M
Article: CANCER. 2015;121(12):2072-2077

Cancer during pregnancy and the postpartum period: A population-based study.

Andersson TM-L; Johansson ALV; Fredriksson I; Lambe M
Article: BMC CANCER. 2015;15:412

The loss in expectation of life after colon cancer: a population-based study.

Andersson TM-L; Dickman PW; Eloranta S; Sjövall A; Lambe M; Lambert PC
Article: BREAST CANCER RESEARCH AND TREATMENT. 2015;151(1):209-217

Family history and risk of pregnancy-associated breast cancer (PABC).

Johansson ALV; Andersson TM-L; Hsieh C-C; Cnattingius S; Dickman PW; Lambe M
Article: BMJ OPEN. 2015;5(4):e006740

Estimating the change in life expectancy after a diagnosis of cancer among the Australian population.

Baade PD; Youlden DR; Andersson TM-L; Youl PH; Kimlin MG; Aitken JF; Biggar RJ
Article: NEUROBIOLOGY OF AGING. 2015;36(4):1751-1756

Apolipoprotein E ε4 genotype and the temporal relationship between depression and dementia.

Karlsson IK; Bennet AM; Ploner A; Andersson TM-L; Reynolds CA; Gatz M; Pedersen NL
Article: CANCER EPIDEMIOLOGY. 2015;39(1):118-125

Understanding the impact of socioeconomic differences in breast cancer survival in England and Wales: avoidable deaths and potential gain in expectation of life.

Rutherford MJ; Andersson TM-L; Møller H; Lambert PC
Article: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2014;71(6):1093-1101

Mortality in women with pregnancy-associated malignant melanoma.

Johansson ALV; Andersson TM-L; Plym A; Ullenhag GJ; Møller H; Lambe M
Article: EPIDEMIOLOGY. 2014;25(5):742-748

The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival.

Eloranta S; Lambert PC; Andersson TM-L; Björkholm M; Dickman PW
Article: BMC CANCER. 2014;14:391

Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden.

Holmes MD; Olsson H; Pawitan Y; Holm J; Lundholm C; Andersson TM-L; Adami H-O; Askling J; Smedby KE
Article: CANCER EPIDEMIOLOGY. 2014;38(1):93-99

Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study.

Andersson TM-L; Eriksson H; Hansson J; Månsson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC
Article: STATISTICS IN MEDICINE. 2013;32(30):5286-5300

Estimating the loss in expectation of life due to cancer using flexible parametric survival models.

Andersson TM-L; Dickman PW; Eloranta S; Lambe M; Lambert PC
Article: CANCER EPIDEMIOLOGY. 2013;37(6):836-842

Estimating the proportion cured of cancer: some practical advice for users.

Yu XQ; De Angelis R; Andersson TML; Lambert PC; O'Connell DL; Dickman PW
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2013;162(4):509-516

Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study.

Shah A; Andersson TM-L; Rachet B; Björkholm M; Lambert PC
Article: BREAST CANCER RESEARCH AND TREATMENT. 2013;139(1):183-192

Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC).

Johansson ALV; Andersson TM-L; Hsieh C-C; Jirström K; Dickman P; Cnattingius S; Lambe M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2013;31(11):1435-1441

Temporal trends in mortality from diseases of the circulatory system after treatment for Hodgkin lymphoma: a population-based cohort study in Sweden (1973 to 2006).

Eloranta S; Lambert PC; Sjöberg J; Andersson TML; Björkholm M; Dickman PW
Article: CANCER CAUSES & CONTROL. 2013;24(3):505-515

How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in Sweden.

Eloranta S; Adolfsson J; Lambert PC; Stattin P; Akre O; Andersson TM-L; Dickman PW
Article: LAKARTIDNINGEN. 2013;110(8):416-419

[Structuring and documenting research projects].

Eloranta S; Johansson ALV; Kristinsson SY; Andersson TM-L
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2013;88(1):60-65

Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005.

Kristinsson SY; Eloranta S; Dickman PW; Andersson TM-L; Turesson I; Landgren O; Björkholm M
Article: INTERNATIONAL JOURNAL OF CANCER. 2013;132(1):155-161

Tobacco use and cancer survival: a cohort study of 40,230 Swedish male construction workers with incident cancer.

Nordenvall C; Nilsson PJ; Ye W; Andersson TM-L; Nyrén O
Article: JOURNAL OF NUTRITIONAL SCIENCE. 2013;2:e15

Mediterranean Diet Score and prostate cancer risk in a Swedish population-based case-control study.

Möller E; Galeone C; Andersson TM-L; Bellocco R; Adami H-O; Andrén O; Grönberg H; La Vecchia C; Mucci LA; Bälter K
Article: STATA JOURNAL. 2012;12(4):623-638

Fitting and modeling cure in population-based cancer studies within the framework of flexible parametric survival models

Andersson TM-L; Lambert PC
Article: PUBLIC HEALTH NUTRITION. 2012;15(10):1897-1908

The Nordic Nutrition Recommendations and prostate cancer risk in the Cancer of the Prostate in Sweden (CAPS) study.

Möller E; Galeone C; Adami H-O; Adolfsson J; Andersson TM-L; Bellocco R; Grönberg H; Mucci LA; Bälter K
Article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(24):2995-3001

Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study.

Hultcrantz M; Kristinsson SY; Andersson TM-L; Landgren O; Eloranta S; Derolf AR; Dickman PW; Björkholm M
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2012;12:86

Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models.

Eloranta S; Lambert PC; Andersson TML; Czene K; Hall P; Björkholm M; Dickman PW
Article: JOURNAL OF TRAUMA AND ACUTE CARE SURGERY. 2012;72(4):954-960

The impact of plasma preparations and their storage time on short-term posttransfusion mortality: a population-based study using the Scandinavian Donation and Transfusion database.

Norda R; Andersson TM-L; Edgren G; Nyren O; Reilly M
Article: BMJ-BRITISH MEDICAL JOURNAL. 2012;344:e900

Screening and cervical cancer cure: population based cohort study.

Andrae B; Andersson TM-L; Lambert PC; Kemetli L; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S; Sparén P
Journal article: BMJ-BRITISH MEDICAL JOURNAL. 2012;344

Screening and cervical cancer cure: population based cohort study

Andrae B; Andersson TM-L; Lambert PC; Kemetli L; Silfverdal L; Strander B; Ryd W; Dillner J; Tornberg S; Sparen P
Journal article: BLOOD. 2011;118(21):3855

Risk and Cause of Death in 9,563 Patients Diagnosed with Myeloproliferative Neoplasms in Sweden Between 1973 and 2005,

Hultcrantz ML; Hinchliffe SR; Kristinsson SY; Andersson TM-L; Eloranta S; Derolf ÅR; Samuelsson J; Landgren O; Dickman PW; Lambert P; Björkholm M
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2011;20(9):1865-1872

Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum.

Johansson ALV; Andersson TM-L; Hsieh C-C; Cnattingius S; Lambe M
Article: BMC MEDICAL RESEARCH METHODOLOGY. 2011;11:96

Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models.

Andersson TML; Dickman PW; Eloranta S; Lambert PC
Article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(18):2514-2520

Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008.

Björkholm M; Ohm L; Eloranta S; Derolf A; Hultcrantz M; Sjöberg J; Andersson T; Höglund M; Richter J; Landgren O; Kristinsson SY; Dickman PW
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2011;20(2):308-317

Dietary phytoestrogens and the risk of ovarian cancer in the women's lifestyle and health cohort study.

Hedelin M; Löf M; Andersson TM-L; Adlercreutz H; Weiderpass E
Journal article: BLOOD. 2010;116(21):205

The Success Story of Targeted Therapy In Chronic Myeloid Leukemia: A Population-Based Study of 3,173 Patients Diagnosed In Sweden 1973–2008

Bjorkholm M; Ohm L; Eloranta S; Derolf ÅR; Hultcrantz M; Sjöberg J; Andersson T; Hoglund M; Richter J; Landgren O; Kristinsson SY; Dickman PW
Article: EUROPEAN JOURNAL OF CANCER. 2010;46(16):2965-2972

Does socioeconomic status influence the prospect of cure from colon cancer--a population-based study in Sweden 1965-2000.

Eloranta S; Lambert PC; Cavalli-Bjorkman N; Andersson TM-L; Glimelius B; Dickman PW
Article: AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS. 2010;153B(6):1160-1166

Association between CYP2C19 polymorphism and depressive symptoms.

Sim SC; Nordin L; Andersson TM-L; Virding S; Olsson M; Pedersen NL; Ingelman-Sundberg M
Article: TRANSFUSION. 2010;50(6):1249-1256

Should plasma from female donors be avoided? A population-based cohort study of plasma recipients in Sweden from 1990 through 2002.

Tynell E; Andersson TML; Norda R; Edgren G; Nyren O; Shanwell A; Reilly M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2010;148(6):918-924

Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study.

Andersson TM-L; Lambert PC; Derolf AR; Kristinsson SY; Eloranta S; Landgren O; Björkholm M; Dickman PW
Article: HAEMATOLOGICA. 2009;94(12):1714-1720

Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.

Kristinsson SY; Björkholm M; Andersson TM-L; Eloranta S; Dickman PW; Goldin LR; Blimark C; Mellqvist U-H; Wahlin A; Turesson I; Landgren O
Journal article: BLOOD. 2009;114(22):1378

Temporal Trends in the Proportion Cured Among Patients Diagnosed with Acute Myeloid Leukemia in Sweden 1973-2001, a Population-Based Study.

Derolf ÅR; Andersson TM-L; Lambert PC; Kristinsson SY; Eloranta S; Landgren O; Dickman PW; Bjorkholm M
Article: OBSTETRICS AND GYNECOLOGY. 2009;114(3):568-572

Increasing incidence of pregnancy-associated breast cancer in Sweden.

Andersson TM-L; Johansson ALV; Hsieh C-C; Cnattingius S; Lambe M
Article: VOX SANGUINIS. 2009;96(4):316-323

Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma.

Shanwell A; Andersson TM-L; Rostgaard K; Edgren G; Hjalgrim H; Norda R; Melbye M; Nyrén O; Reilly M
Article: BLOOD. 2009;113(16):3666-3672

Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005.

Derolf AR; Kristinsson SY; Andersson TM-L; Landgren O; Dickman PW; Björkholm M
Article: INTERNATIONAL JOURNAL OF CANCER. 2007;121(9):2052-2059

Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer Registry.

Lambert PC; Dickman PW; Österlund P; Andersson T; Sankila R; Glimelius B
Visa fler

Alla övriga publikationer

Corrigendum: EUROPEAN JOURNAL OF CANCER. 2024;201:113940

Corrigendum to "Despite multi-disciplinary team discussions the socioeconomic disparities persist in the oncological treatment of non-metastasized colorectal cancer" [Eur J Cancer 199 (2024) 113572].

Osterman E; Syriopoulou E; Martling A; Andersson TM-L; Nordenvall C
Conference publication: ANNALS OF ONCOLOGY. 2023;34:s948

Re-ranking cancer mortality using years of life lost

Radkiewicz C; Andersson TM-L; Lagergren J
Conference publication: BLOOD. 2022;140:6856-6857

Patterns of Childbirth in Women with Myeloproliferative Neoplasms

Landtblom AR; Andersson TML; Johansson ALV; Lundberg FE; Samuelsson J; Bjorkholm M; Hultcrantz M
Preprint: RESEARCH SQUARE. 2022

Exploring different multi-state structures when studying patterns of antidepressant medication use in women with breast cancer and matched healthy controls

Skourlis N; Crowther MJ; Andersson TM-L; Lu D; Lambe M; Lambert PC
Preprint: RESEARCH SQUARE. 2022

Modelling multiple time-scales with flexible parametric survival models

Batyrbekova N; Bower H; Dickman PW; Landtblom AR; Hultcrantz M; Szulkin R; Lambert PC; Andersson TM-L
Preprint: RESEARCH SQUARE. 2021

Non-Parametric Estimation of Reference Adjusted, Standardised Probabilities of All-Cause Death and Death Due to Cancer for Population Group Comparisons

Rutherford MJ; Andersson TM-L; Myklebust TÅ; Møller B; Lambert PC
Preprint: RESEARCH SQUARE. 2021

Development of a dynamic interactive web tool to enhance understanding of multi-state model analyses: MSMplus

Skourlis N; Crowther MJ; Andersson TM-L; Lambert PC
Preprint: RESEARCH SQUARE. 2021

On Estimating Survival and Hazard Ratios Using One Time-Scale When Cohort Data Have Multiple Time-Scales: A Simulation Study

Batyrbekova N; Bower H; Dickman P; Szulkin R; Lambert PC; Andersson TM-L
Review: JOURNAL OF INTERNAL MEDICINE. 2021;289(1):12-28

Cancer survival statistics for patients and healthcare professionals - a tutorial of real-world data analysis.

Eloranta S; Smedby KE; Dickman PW; Andersson TM
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:70

Excess deaths associated with treatment resistance in patients with major depressive disorder

Brenner P; Brandt L; Nijs M; Reutfors J; Andersson T
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:84-85

Occurrence of metabolic risk factors stratified by psoriasis severity: A Swedish population-based matched cohort study

Hagg D; Linder M; Hajiebrahimi M; Song C; Andersson TM-L; Villacorta R
Conference publication: JOURNAL OF UROLOGY. 2020;203:E247-E248

REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

Vigneswaran HT; Warnqvist A; Andersson TML; Leval A; Schain F; Liwing J; Eloranta S; Pettersson A; Akre O; Aly M
Review: CANCER EPIDEMIOLOGY. 2019;60:168-173

Loss in life expectancy and gain in life years as measures of cancer impact.

Rutherford MJ; Andersson TM-L; Björkholm M; Lambert PC
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(15):e16555

Survival in men diagnosed with castration resistant prostate cancer: A population-based observational study in Sweden.

Aly M; Schain F; Leval A; Liwing J; Lawson J; Vago E; Nordstrom T; Gronberg H; Andersson TM-L; Sjoland E; Wang C; Eloranta S; Akre O
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2019;28:99

Risk factors for suicide and suicide attempts among patients with treatment resistant depression: A population based nested case-control study

Brenner P; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Reutfors J
Conference publication: BLOOD. 2018;132:930

Relapse Risk and Loss in Expectation of Lifetime in Young Classical Hodgkin Lymphoma Patients - a Nordic Lymphoma Group Study of 2,582 Patients

Biccler JL; Glimelius I; Eloranta S; Smeland KB; Brown PDN; Jakobsen LH; Frederiksen H; Jerkeman M; Fossa A; Andersson TML; Holte HJ; Bogsted M; El-Galaly TC; Smedby KE
Letter: ANNALS OF INTERNAL MEDICINE. 2018;169(4):268

Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms.

Hultcrantz M; Björkholm M; Landgren O; Kristinsson SY; Andersson TML
Corrigendum: EUROPEAN JOURNAL OF CANCER. 2017;87:219-220

Corrigendum to "Avoidable cancer cases in the Nordic countries - The impact of overweight and obesity" [Eur J Cancer 79 (2017) 106-118].

Andersson TM-L; Weiderpass E; Engholm G; Lund A-SQ; Olafsdottir E; Pukkala E; Stenbeck M; Storm H
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S852

All-cause mortality in treatment-resistant depression: a register-based cohort study in Sweden

Reutfors J; Andersson T; Brandt L; Dibernardo A; Li G; Westerlund A; Wingard L; Boden R
Letter: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(6):696-697

Reply to D. Pulte et al.

Bower H; Björkholm M; Dickman PW; Höglund M; Lambert PC; Andersson TM-L
Meeting abstract: BLOOD. 2016;128(22):946

Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden

Creignou M; Bower H; Andersson TM-L; Landtblom AR; Dickman PW; Bjorkholm M; Kristinsson SY; Hultcrantz M
Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(24):2851-2857

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.

Bower H; Björkholm M; Dickman PW; Höglund M; Lambert PC; Andersson TM-L
Published conference paper: STATISTICS IN MEDICINE. 2016;35(7):1193-1209

Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification.

Crowther MJ; Andersson TM-L; Lambert PC; Abrams KR; Humphreys K
Conference publication: CANCER RESEARCH. 2016;76:p6-10-07-p6-10-07

Family history and risk of pregnancy-associated breast cancer (PABC)

Lambe M; Johansson ALV; Andersson TM; Hsieh C-C; Cnattingius S; Dickman PW
Conference publication: HAEMATOLOGICA. 2016;101:6-7

INCREASED RISK OF SECOND MALIGNANCIES IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS DIAGNOSED IN SWEDEN 1973-2009. A POPULATION-BASED COHORT STUDY OF 9,379 PATIENTS

Landtblom AR; Bower H; Andersson TML; Dickman PW; Bjorkholm M; Kristinsson SY; Hultcrantz M
Conference publication: BLOOD. 2015;126(23):1605

A Population-Based Study of Incidence of Myeloproliferative Neoplasms in Sweden Between 2000 and 2012

Hultcrantz M; Andersson TM-L; Landgren O; Dickman PW; Andreasson B; Bjorkholm M; Kristinsson SY
Conference publication: BLOOD. 2015;126(23):2779

Temporal Trends in Chronic Myeloid Leukemia Outcome Using the Loss in Expectation of Life: A Swedish Population-Based Study

Bjorkholm M; Bower H; Dickman PW; Lambert PC; Hoglund M; Andersson TM-L
Meeting abstract: PSYCHONEUROENDOCRINOLOGY. 2015;61:50

Increased risk for psychiatric disorders immediately before and after cancer diagnosis: A nationwide matched cohort study in Sweden

Lu D; Andersson TM-L; Fall K; Hultman CM; Czene K; Valdimarsdottir U; Fang F
Conference publication: HAEMATOLOGICA. 2015;100:260-261

MYELOPROLIFERATIVE NEOPLASMS AND INFECTIONS; A POPULATION-BASED STUDY ON 9,665 PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS DIAGNOSED IN SWEDEN 1987-2009

Hultcrantz M; Lund SH; Andersson TM-L; Bjorkholm M; Kristinsson SY
Conference publication: HAEMATOLOGICA. 2015;100:193

CONTINUED IMPROVEMENT IN SURVIVAL OF ACUTE MYELOID LEUKEMIA PATIENTS AND AN APPLICATION OF THE LOSS IN EXPECTATION OF LIFE

Bower H; Andersson TM-L; Bjorkholm M; Dickman P; Lambert P; Derolf A
Meeting abstract: BLOOD. 2014;124(21):632

Risk of Arterial and Venous Thrombosis in 11,155 Patients with Myeloproliferative Neoplasms and 44,620 Matched Controls; A Population-Based Study

Hultcrantz M; Andersson TM-L; Landgren O; Derolf AR; Dickman PW; Bjorkholm M; Kristinsson SY
KI thesis / dissertation: 2013

Quantifying cancer patient survival : extensions and applications of cure models and life expectancy estimation

Andersson, Therese M L
Conference publication: HAEMATOLOGICA. 2013;98:219

TEMPORAL TRENDS IN MORTALITY FROM DISEASES OF THE CIRCULATORY SYSTEM AFTER TREATMENT FOR HODGKIN LYMPHOMA - A POPULATION-BASED COHORT STUDY IN SWEDEN (1973-2006)

Bjorkholm M; Eloranta S; Lambert P; Andersson T; Sjoberg J; Dickman P
Conference publication: CANCER RESEARCH. 2011;71:p1-08-09-p1-08-09

Increased Mortality in Swedish Women Diagnosed with Breast Cancer during and Shortly after Pregnancy.

Johansson ALV; Andersson TM-L; Cnattingius S; Hsieh C-C; Lambe M
Letter: TRANSFUSION. 2011;51(2):445-446

Response to "Alternate analysis strategies for retrospective assessment of outcomes with a male donor-only plasma policy" by Welsby, Stafford-Smith, and Phillips-Bute

Reilly M; Nyren O; Andersson TM-L; Edgren G; Norda R; Shanwell A; Tynell E
Conference publication: PEDIATRIC BLOOD & CANCER. 2011;57(5):823

TRENDS IN SURVIVAL AND THE PROPORTION CURED OF ADULT ACUTE MYELOID LEUKAEMIA IN ENGLAND, 1971-2006: A POPULATION-BASED STUDY

Shah A; Andersson T; Rachet B; Burnett A; Lambert P
Conference publication: BLOOD. 2011;118(21):1648-1649

Risk and Cause of Death in 9,563 Patients Diagnosed with Myeloproliferative Neoplasms in Sweden Between 1973 and 2005

Hultcrantz ML; Hinchliffe SR; Kristinsson SY; Andersson TM-L; Eloranta S; Derolf AR; Samuelsson J; Landgren O; Dickman PW; Lambert P; Bjorkholm M
Meeting abstract: BLOOD. 2010;116(21):1266-1267

Patterns of Survival and Causes of Death In 9,384 Patients with Myeloproliferative Neoplasms Diagnosed In Sweden Between 1973 and 2008

Hultcrantz M; Kristinsson SY; Andersson TM-L; Eloranta S; Derolf AR; Landgren O; Dickman PW; Bjorkholm M
Conference publication: BLOOD. 2010;116(21):93-94

The Success Story of Targeted Therapy In Chronic Myeloid Leukemia: A Population-Based Study of 3,173 Patients Diagnosed In Sweden 1973-2008

Bjorkholm M; Ohm L; Eloranta S; Derolf AR; Hultcrantz M; Sjoberg J; Andersson T; Hoglund M; Richter J; Landgren O; Kristinsson SY; Dickman PW
Conference publication: HAEMATOLOGICA. 2010;95:470

PATTERNS OF SURVIVAL AMONG 7,249 PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS DIAGNOSED IN SWEDEN 1973-2003

Hultcrantz L; Kristinsson S; Andersson T; Eloranta S; Derolf A; Landgren O; Dickman P; Bjorkholm M
Conference publication: BLOOD. 2009;114(22):561

Temporal Trends in the Proportion Cured Among Patients Diagnosed with Acute Myeloid Leukemia in Sweden 1973-2001, a Population-Based Study

Derolf AR; Andersson TM-L; Lambert PC; Kristinsson SY; Eloranta S; Landgren O; Dickman PW; Bjorkholm M
Conference publication: HAEMATOLOGICA. 2009;94:157

PATTERNS OF SURVIVAL AND CAUSES OF DEATH FOLLOWING A DIAGNOSIS OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: A POPULATION-BASED STUDY

Kristinsson SY; Bjorkholm M; Andersson TML; Eloranta S; Dickman PW; Goldin LR; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
Scholarly edition:

Estimating and modeling cure within the framework of flexible parametric survival models

Andersson TM-L; Eloranta S; Dickman PW; Lambert PC
Visa fler

Utvalda forskningsbidrag

Development of flexible parametric survival models with multiple time-scales – with applications to Myeloproliferative Neoplasm (MPN)

Swedish Research Council

1 January 2020 - 31 December 2023
Development of flexible parametric survival models with multiple time-scales – with applications to Myeloproliferative Neoplasm (MPN)

Swedish Cancer Society

1 January 2019

Forskningsbidrag

Extensions and applications of loss in life expectancy for cancer patients

Swedish Research Council

1 January 2024 - 31 December 2026
Extensions and applications of loss in life expectancy for cancer patients

Cancerfonden

1 January 2023 - 31 December 2025

Anställningar

Lektor, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2020-
Postdoctoral Researcher, Danish Cancer Society, 2015-2016
Postdoktor, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2014-2015

Examina och utbildning

Docent, Biostatistik, Karolinska Institutet, 2020
Medicine Doktorsexamen, Institutionen för medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2013
MSc, Mathematical Statistics, Uppsala University, 2007

Handledare

Anna Warnqvist, Loss of life expectancy for patients with malignant melanoma, by socioeconomic groups and sex, 2023
Yuliya Leontyeva, Development, extensions and applications of statistical models in population-based studies to estimate loss in expectation of life (LEL) due to cancer., 2019
Nurgul Betyrbekova, Modeling multiple time-scales with flexible parametric survival models – with applications to Myeloproliferative Neoplasm (MPN), 2019
Hannah Bower, Flexible parametric models for cancer patient survival: loss in expectation of life and further developments, https://openarchive.ki.se/xmlui/bitstream/handle/10616/46179/Thesis_Hannah_Bower.pdf?sequence=1&isAllowed=y

Om mig

Artiklar

Alla övriga publikationer

Utvalda forskningsbidrag

Forskningsbidrag

Anställningar

Examina och utbildning

Handledare

Nyheter från KI

Kalenderhändelser från KI